To report a methodology for the construction of supramolecular architectures to obtain isostructural compounds through the diversion of the structures, a series of mercury complexes containing N-(3-halophenyl)-2-pyridinecarboxamide ligands, have been synthesized for a systematic.
Quantitative similarity indices (IX) were combined with crystallization mechanism proposals to shed more light on the origins of the supramolecular similarity between a series of benzimidazole derivative structures.
Isostructurality was investigated for the molecular salts of two carboxylates. The luminescence properties of the solid solutions of 4apy salts of these carboxylates indicate that this property can be used to fine tune the physical properties.
Acalabrutinib, an anti-cancer drug, was approved by the USFDA in 2017.
Sulfathiazole shows one of the most extensive solid-form landscapes known to date for an active pharmaceutical ingredient. A standardised structure set of 5 polymorphs, 59 co-crystals, 29 salts, and 3 other structures is established.